Arcturus Therapeutics Holdings Inc. (ARCT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 167.88M |
| Enterprise Value | -38.03M |
| P/E Ratio | -2.55 |
| PEG Ratio | 0.16 |
| Price/Sales Ratio | 4.53 |
| Price/Book Ratio | 1.07 |
| Enterprise/Revenue | 0.4 |
| Enterprise/EBITDA | -0.27 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.73 |
| Operating Margin | -1.97 |
| Return On Assets | -0.32 |
| Return On Equity | -0.37 |
| Revenue | 67.22M |
| Revenue/Share | 1.6 |
| Gross Profit | 64.2M |
| EBITDA | -62.76M |
| Net Income | -65.78M |
| Diluted EPS | -2.4 |
| Total Cash | 211.38M |
| Total Cash/Share | 7.44 |
| Total Debt | 23.99M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 6.31 |
| Book Value Per Share | 6.73 |
| 52-Week Change | -42.21 |
| 52-Week High | 24.17 |
| 52-Week Low | 5.85 |
| Moving Average 50 Days | 7.96 |
| Moving Average 200 Days | 9.72 |
| Average Volume | 423,977 |
| Shares Outstanding | 28.42M |
| % Held by Institutions | 88.69 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
| Last Split Date | November 16, 2017 |